HHLR Advisors, LTD.
HHLR Advisors, LTD. is an exempt reporting adviser based in Singapore, Singapore that reports managing 2 hedge funds on Form ADV. Its private funds, of all types, hold $22.1 billion in gross assets. Its disclosed U.S. stock holdings returned an estimated -16.7% 2026 YTD through Jun 30 (S&P 500: +9.5%), based on 13F filings. Over a longer period they returned an estimated +10.4% from Q3 2024 to Q2 2026, compared with +37.2% for the S&P 500, based on 13F filings.
- Regulatory assets under management
- —Form ADV Item 5.F
- Gross assets of private funds
- $22.1 billionAll private fund types, Form ADV
- Hedge funds managed
- 22 private funds in total
- Employees
- —Form ADV Item 5.A
- Registration
- Exempt reporting adviserCRD 166112
- Latest Form ADV
- 03/31/2026Disciplinary disclosures: none reported
Estimated 13F portfolio performance
Estimated by AltMountain, derived from the firm’s public Form 13F filings. Not reported by the firm and not the return of any fund.
| Quarter | Est. 13F return | S&P 500 |
|---|---|---|
| Q2 2026 | -5.9% | +14.8% |
| Q1 2026 | -11.5% | -4.6% |
| Q4 2025 | -16.4% | +2.4% |
| Q3 2025 | +23.8% | +7.8% |
| Q2 2025 | -0.9% | +10.4% |
| Q1 2025 | +25.3% | -4.5% |
| Q4 2024 | -16.6% | +2.1% |
| Q3 2024 | +23.6% | +5.4% |
Estimate of the firm's disclosed long U.S. stock portfolio from its quarterly 13F filings, holding each quarter-end portfolio to the next quarter-end at prices implied by all 13F filers. It is a price return before dividends and fees, ignores shorts, options, bonds, cash and trading within the quarter, and is not the return of any fund. Disclosures
Manager of this firm? Report your fund’s actual net return, or email hello@altmountain.com to correct or remove this estimate. Removal requests from the firm are honored.
13F holdings as of Sep 30, 2026
All 40 share positions ($1,543,219,087) reported by HHLR Advisors, LTD. on Form 13F for the quarter ended Sep 30, 2026, filed Nov 16, 2026. Shown as filed with the SEC. Original filing on SEC.gov ↗ The estimated return above runs through Jun 30, 2026; it is updated when the SEC publishes its complete data for the quarter.
Share of the reported 13F portfolio, ten largest positions
- PDD Holdings Inc22.46%
- Alibaba Group Hldg LTD17.35%
- Legend Biotech Corp10.78%
- Full Truck Alliance Co LTD10.50%
- Arrivent Biopharma Inc7.71%
- Vipshop Hldgs LTD5.56%
- Trip Com Group LTD5.39%
- Futu Hldgs LTD4.52%
- Marvell Technology Inc2.64%
- Cytek Biosciences Inc2.57%
| Stock | Value | % of 13F portfolio | Shares | Shares vs prior quarter |
|---|---|---|---|---|
| PDD Holdings Inc | $346,599,180 | 22.46% | 4,447,000 | +789.40% |
| Alibaba Group Hldg LTD | $267,753,092 | 17.35% | 2,489,800 | +1,253.64% |
| Legend Biotech Corp | $166,308,763 | 10.78% | 8,361,426 | +39.72% |
| Full Truck Alliance Co LTD | $162,065,966 | 10.50% | 19,596,852 | New |
| Arrivent Biopharma Inc | $118,973,663 | 7.71% | 3,929,117 | Unchanged |
| Vipshop Hldgs LTD | $85,726,026 | 5.56% | 6,852,600 | +97.46% |
| Trip Com Group LTD | $83,177,430 | 5.39% | 2,127,300 | New |
| Futu Hldgs LTD | $69,757,050 | 4.52% | 631,000 | -64.32% |
| Marvell Technology Inc | $40,670,638 | 2.64% | 153,933 | -5.52% |
| Cytek Biosciences Inc | $39,675,899 | 2.57% | 6,657,030 | Unchanged |
| Alamar Biosciences Inc | $32,586,660 | 2.11% | 956,462 | Unchanged |
| Odyssey Therapeutics Inc | $18,479,396 | 1.20% | 831,656 | Unchanged |
| Yatsen Hldg LTD | $13,582,727 | 0.88% | 4,885,873 | Unchanged |
| Maze Therapeutics Inc | $9,948,695 | 0.64% | 366,030 | Unchanged |
| Contineum Therapeutics Inc | $8,982,503 | 0.58% | 669,337 | Unchanged |
| Agora Inc | $8,771,952 | 0.57% | 2,098,553 | Unchanged |
| Taiwan Semiconductor Manufac | $8,625,184 | 0.56% | 18,907 | +21.90% |
| Novabridge Biosciences | $8,163,475 | 0.53% | 5,980,568 | Unchanged |
| Cerebras Systems Inc | $7,637,884 | 0.49% | 42,994 | New |
| Amazon Com Inc | $6,028,932 | 0.39% | 24,198 | New |
| Ke Hldgs Inc | $4,542,962 | 0.29% | 269,612 | -87.85% |
| Netease Com Inc | $4,240,479 | 0.27% | 34,999 | Unchanged |
| Intel Corp | $4,170,538 | 0.27% | 34,688 | +142.57% |
| Nvidia Corporation | $3,209,653 | 0.21% | 14,054 | Unchanged |
| Ge Aerospace | $3,136,328 | 0.20% | 10,043 | Unchanged |
| Tuya Inc | $2,659,480 | 0.17% | 1,564,400 | Unchanged |
| Pacific Biosciences Calif In | $2,177,774 | 0.14% | 918,892 | Unchanged |
| Alphabet Inc | $1,996,352 | 0.13% | 5,802 | New |
| Microsoft Corp | $1,866,956 | 0.12% | 3,640 | New |
| Lumentum Hldgs Inc | $1,699,705 | 0.11% | 1,750 | -46.97% |
| Paypay Corp | $1,635,548 | 0.11% | 104,175 | New |
| Mogu Inc | $1,576,369 | 0.10% | 847,510 | Unchanged |
| SK Hynix Inc Fsponsored ADR 1 ADR Reps 0.1 ORD SHS | $1,478,356 | 0.10% | 8,028 | New |
| S&P Global Inc | $1,227,591 | 0.08% | 3,112 | New |
| Moodys Corp | $1,207,532 | 0.08% | 2,659 | New |
| Equinox Gold Corp | $894,355 | 0.06% | 80,500 | Unchanged |
| Zoom Communications Inc | $817,838 | 0.05% | 9,010 | Unchanged |
| Gossamer Bio Inc | $736,774 | 0.05% | 62,175 | New |
| Aligos Therapeutics Inc | $429,271 | 0.03% | 76,247 | Unchanged |
| Ridgetech Inc | $111 | 0.00% | 135 | -0.74% |
Changes since Jun 30, 2026
Comparing the share counts in the two quarter-end filings: 11 new positions, 6 sold out, 6 increased, 5 reduced and 18 unchanged.
Number of positions (a count, not dollars)
- New positions11
- Increased6
- Unchanged18
- Reduced5
- Sold out6
New positions
| Stock | Value | Shares |
|---|---|---|
| Full Truck Alliance Co LTD | $162,065,966 | 19,596,852 |
| Trip Com Group LTD | $83,177,430 | 2,127,300 |
| Cerebras Systems Inc | $7,637,884 | 42,994 |
| Amazon Com Inc | $6,028,932 | 24,198 |
| Alphabet Inc | $1,996,352 | 5,802 |
| Microsoft Corp | $1,866,956 | 3,640 |
| Paypay Corp | $1,635,548 | 104,175 |
| SK Hynix Inc Fsponsored ADR 1 ADR Reps 0.1 ORD SHS | $1,478,356 | 8,028 |
| S&P Global Inc | $1,227,591 | 3,112 |
| Moodys Corp | $1,207,532 | 2,659 |
| Gossamer Bio Inc | $736,774 | 62,175 |
Sold out
| Stock | Value at Jun 30, 2026 | Shares held then |
|---|---|---|
| Sagimet Biosciences Inc | $5,602,704 | 724,800 |
| Corning Inc | $2,622,244 | 10,266 |
| Coherent Corp | $2,531,314 | 6,417 |
| Webull Corp | $2,020,268 | 309,857 |
| Texas Instrs Inc | $1,430,736 | 4,800 |
| Gossamer Bio Inc | $818,727 | 4,974,041 |
Largest increases
| Stock | Change in shares | Change | Value now | Shares now |
|---|---|---|---|---|
| PDD Holdings Inc | +3,947,000 | +789.40% | $346,599,180 | 4,447,000 |
| Alibaba Group Hldg LTD | +2,305,866 | +1,253.64% | $267,753,092 | 2,489,800 |
| Legend Biotech Corp | +2,376,876 | +39.72% | $166,308,763 | 8,361,426 |
| Vipshop Hldgs LTD | +3,382,200 | +97.46% | $85,726,026 | 6,852,600 |
| Intel Corp | +20,388 | +142.57% | $4,170,538 | 34,688 |
| Taiwan Semiconductor Manufac | +3,397 | +21.90% | $8,625,184 | 18,907 |
Largest reductions
| Stock | Change in shares | Change | Value now | Shares now |
|---|---|---|---|---|
| Futu Hldgs LTD | -1,137,283 | -64.32% | $69,757,050 | 631,000 |
| Ke Hldgs Inc | -1,948,765 | -87.85% | $4,542,962 | 269,612 |
| Marvell Technology Inc | -9,000 | -5.52% | $40,670,638 | 153,933 |
| Lumentum Hldgs Inc | -1,550 | -46.97% | $1,699,705 | 1,750 |
| Ridgetech Inc | -1 | -0.74% | $111 | 135 |
Each list shows up to 20 positions, largest first by dollar amount. Changes compare two quarter-end snapshots, with the earlier share count adjusted for stock splits AltMountain detected. They do not show when, or at what price, anything was bought or sold.
From public Form 13F filings, not verified. Form 13F is filed up to 45 days after the quarter ends, so positions may have changed. It lists only certain long positions in U.S.-listed stocks and exchange-traded funds; options are not shown here, and short positions, most bonds, cash, non-U.S. securities and private investments are not reported at all, so a holding may be one side of a hedge. A filing covers the manager as a whole, not any single fund, and filings contain errors. This is not investment advice or a recommendation to buy or sell any security. Disclosures
Large ownership stakes (Schedule 13D and 13G)
| Company | Filing | Percent of class | Shares | Filed | Source |
|---|---|---|---|---|---|
| NovaBridge Biosciences | 13D amendment | 4.9% | 13,295,306 | Nov 5, 2026 | SEC.gov ↗ |
A firm files Schedule 13G (passive) or 13D (it may seek to influence the company) when it beneficially owns more than 5% of a class of a public company's shares. Each row is the firm's latest such filing for that company since Nov 5, 2026, exactly as filed, and counts shares held across the firm and its affiliates, not by any single fund. An amendment can report a stake that has fallen below 5%. Holdings may have changed since the filing date. Not verified by AltMountain. Source: U.S. Securities and Exchange Commission, EDGAR.
Private funds reported on Form ADV (4)
As reported in the adviser's Form ADV filed Mar 29, 2024. Funds also listed from Form D are shown above.
From SEC filings. Firm data comes from the SEC's Form ADV data as of Oct 2, 2026; performance estimates come from Form 13F. AltMountain has not verified this information, and it is not an offer, solicitation or recommendation. Full disclosures